Connect with us

News

Research Reveals Compromised Transfer Of SARS-Cov-2-Specific Antibodies Through Placenta

The scientists found that altered attachments of carbohydrates to the SARS-CoV-2-specific antibodies — a process called glycosylation — may be to blame for this reduced transfer from mother to fetus in the third trimester

Research Reveals Compromised Transfer Of SARS-Cov-2-Specific Antibodies Through Placenta
Highlights
  • Maternal antibodies were compared against flu, whooping cough, SARS-CoV-2
  • Influenza- and pertussis-specific antibodies were actively transferred
  • SARS-CoV-2-specific antibodies transferred to the baby were less functional

Washington: Recent analyses indicate that pregnant women and newborns may face elevated risks of developing more severe cases of COVID-19 following SARS-CoV-2 infection. New research led by investigators at Massachusetts General Hospital (MGH) and published in Cell reveals lower than expected transfer of protective SARS-CoV-2 antibodies via the placenta from mothers who are infected in the third trimester. The cause may be alterations to these antibodies after they’re produced–a process called glycosylation.
The results expand on the team’s recent findings published in JAMA Network Open that pregnant women with COVID-19 pass no SARS-CoV-2 virus, but also relatively low levels of antibodies against it, to newborns.

Also Read: COVID-19 Immunity Lasts At Least Eight Months, Hope For Longevity Of Vaccinations: Study

For this latest study, the scientists compared maternal antibodies against the flu (influenza), whooping cough (pertussis), and SARS-CoV-2, and how these antibodies transferred across the placenta.

Influenza- and pertussis-specific antibodies were actively transferred in a relatively normal fashion. In contrast, transfer of SARS-CoV-2-specific antibodies to the baby was not only significantly reduced, but the antibodies transferred were less functional than the antibodies against influenza. The reduced transfer was only observed in third trimester infection.

Also Read: Study Sheds Light On Immunity Transfer From COVID-19 Positive Mothers To Babies

The scientists found that altered attachments of carbohydrates to the SARS-CoV-2-specific antibodies — a process called glycosylation — may be to blame for this reduced transfer from mother to fetus in the third trimester.

The carbohydrate attachments on SARS-CoV-2-specific antibodies in maternal blood were different than those seen on influenza- and pertussis-specific antibodies. This carbohydrate pattern may cause the COVID-specific antibodies to be “stuck” in the maternal circulation, rather than transferred across the placenta via placental antibody receptors.

Infection-induced increases in total maternal antibodies, as well as higher placental expression of an antibody receptor that attracts the carbohydrate pattern on the SARS-CoV-2-specific antibodies, helped to partially overcome the problem and facilitate the transfer of some functional antibodies from mother to fetus.

Interestingly, some of the antibodies that transferred the best were also the most functional, activating natural killer cells that could help the newborn fight the virus if exposed.

Also Read: A Pandemic Atlas: How COVID-19 Took Over The World In 2020

The findings have implications for the design of vaccines against SARS-CoV-2 for pregnant women.

“Vaccine regimens able to drive high levels of the COVID-specific antibodies with glycosylation patterns favored by the placenta for selective transfer to the fetus may lead to better neonatal and infant protection,” said co-senior author Andrea Edlow, MD, MSc, a maternal-fetal medicine specialist at MGH and an assistant professor of Obstetrics, Gynecology, and Reproductive Biology at Harvard Medical School.

“We are beginning to define the rules of placental antibody transfer of SARS-CoV-2 for the very first time — catalyzing our ability to rationally design vaccines to protect pregnant women and their newborns,” Co-senior author and Core Member at the Ragon Institute of MGH, MIT and Harvard, Galit Alter, PhD, said.

In addition, understanding how antibody transfer varies by trimester may point to critical windows in pregnancy that may be most desirable for vaccination to optimize protection for both the mother and her infant.

Also Read: COVID-19 Patients At Five Times Higher Risk Of Death Than Those With Flu: Study

(Except for the headline, this story has not been edited by NDTV staff and is published from a syndicated feed.)

NDTV – Dettol Banega Swasth India campaign is an extension of the five-year-old Banega Swachh India initiative helmed by Campaign Ambassador Amitabh Bachchan. It aims to spread awareness about critical health issues facing the country. In wake of the current COVID-19 pandemic, the need for WASH (WaterSanitation and Hygiene) is reaffirmed as handwashing is one of the ways to prevent Coronavirus infection and other diseases. The campaign highlights the importance of nutrition and healthcare for women and children to prevent maternal and child mortality, fight malnutrition, stunting, wasting, anaemia and disease prevention through vaccines. Importance of programmes like Public Distribution System (PDS), Mid-day Meal Scheme, POSHAN Abhiyan and the role of Aganwadis and ASHA workers are also covered. Only a Swachh or clean India where toilets are used and open defecation free (ODF) status achieved as part of the Swachh Bharat Abhiyan launched by Prime Minister Narendra Modi in 2014, can eradicate diseases like diahorrea and become a Swasth or healthy India. The campaign will continue to cover issues like air pollutionwaste managementplastic banmanual scavenging and sanitation workers and menstrual hygiene

Highlights Of The 12-Hour Telethon

Reckitt’s Commitment To A Better Future

India’s Unsung Heroes

Women’s Health

हिंदी में पड़े

Folk Music For A Swasth India

RajasthanDay” src=